Â鶹ŮÓÅ

Return to the Full Article View You can republish this story for free. Click the "Copy HTML" button below. Questions? Get more details.

KHN’s ‘What the Health?’: The Drug Price Dilemma

Can’t see the audio player? . You can also listen on ´Ç²ÔÌý, ,Ìý, or wherever you listen to podcasts.

The high cost of prescription drugs is among consumers’ top health policy issues, according to public opinion polls. And it’s one of the few health issues that Republicans and Democrats agree needs addressing. Yet try as they might, policymakers have been able to make only incremental changes in drug price policy during the past three decades.

Why is lowering drug prices so hard? The political clout of the powerful drug industry plays a role. Also, the problem is particularly complex because drugs pass through so many hands between manufacturing and the pickup at the pharmacy counter.

This week KHN’s “What the Health?” podcast takes a deep dive into the policy and politics of prescription drug prices. First, host Julie Rovner talks with Stacie Dusetzina, a drug price researcher and associate professor at Vanderbilt University.

Then panelists , and join Rovner for a discussion of the prospects for policy change.

To hear all our podcasts,Ìýclick here.

And subscribe to KHN’s What the Health? ´Ç²ÔÌý, ,Ìý, or wherever you listen to podcasts.

Â鶹ŮÓÅ Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at Â鶹ŮÓÅ—an independent source of health policy research, polling, and journalism. Learn more about .

Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.